• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[聚合物-药物复合物在广泛期卵巢癌治疗中的应用]

[Polymer-drug complexes in the treatment of extensive ovarian cancer].

作者信息

Novikova E G, Borisov V I, Dmitriev D G, Zel'vin B M, Karseladze A I, Shchitkov K G, Li A D

出版信息

Sov Med. 1991(11):27-9.

PMID:1767307
Abstract

The paper presents the results of intracavitary chemotherapy with deposited cytostatics of advanced ovarian cancer as well experimental, morphological, biochemical and pharmacological data. Intraabdominal introduction of microspheres filled with cyclophosphamide, 5-fluorouracil, doxorubicin can be a variant of drug therapy in multimodality treatment of ovarian cancer. Combination of intracavitary chemotherapy with a systemic one has the advantage of local and regional effect which is not inhibited by mediated action of the deposited cytostatics via the systemic blood flow. The method is indicated in residual tumor dissemination after cytoreductive surgery and ovarian cancer with ascites.

摘要

本文介绍了晚期卵巢癌腔内化疗联合植入细胞抑制剂的结果,以及实验、形态学、生化和药理学数据。腹腔内植入填充有环磷酰胺、5-氟尿嘧啶、阿霉素的微球可作为卵巢癌多模式治疗中药物治疗的一种方式。腔内化疗与全身化疗相结合具有局部和区域作用的优势,不会受到植入细胞抑制剂通过全身血流介导作用的抑制。该方法适用于减瘤手术后残留肿瘤播散和伴有腹水的卵巢癌。

相似文献

1
[Polymer-drug complexes in the treatment of extensive ovarian cancer].[聚合物-药物复合物在广泛期卵巢癌治疗中的应用]
Sov Med. 1991(11):27-9.
2
[Use of cytostatics deposited in cellulose acetate microspheres in the treatment of ovarian cancer].[醋酸纤维素微球中沉积的细胞抑制剂在卵巢癌治疗中的应用]
Sov Med. 1989(10):37-9.
3
[A randomized clinical trial of cyclophosphamide versus adriamycin, cyclophosphamide, 5-fluorouracil and methotrexate in advanced ovarian carcinoma--a preliminary report ].
Lijec Vjesn. 1982 Mar-Apr;104(3-4):120-2.
4
Controlled prospective trial of combination chemotherapy with cyclophosphamide, adriamycin, and 5-fluorouracil for the treatment of advanced ovarian cancer: a preliminary report.
Cancer Treat Rep. 1979 Feb;63(2):297-9.
5
Subrenal capsule assay as a predictor of clinical response of ovarian cancer to chemotherapy: Part II.肾包膜下测定作为卵巢癌化疗临床反应预测指标:第二部分。
Obstet Gynecol. 1985 Nov;66(5):714-8.
6
Hexa-CAF combination chemotherapy and other multiple-drug regimens in advanced ovarian carcinoma: present and future.
Neth J Med. 1979;22(2):38-44.
7
[Metastatic brain tumor after chemotherapy of ovarian cancer].卵巢癌化疗后发生的脑转移瘤
Gan No Rinsho. 1987 Jan;33(1):115-8.
8
[Controlled prospective study of chemotherapy in advanced ovarian cancer--cyclophosphamide monochemotherapy versus polychemotherapy with adriamycin, cyclophosphamide, 5-fluorouracil and methotrexate].晚期卵巢癌化疗的对照前瞻性研究——环磷酰胺单药化疗与阿霉素、环磷酰胺、5-氟尿嘧啶和甲氨蝶呤联合化疗的对比
Lijec Vjesn. 1987 Jun;109(6):230-4.
9
Advanced ovarian cancer: brief intensive combination chemotherapy and second-look operation.
Obstet Gynecol. 1981 Aug;58(2):199-205.
10
[Clinical trial of cisplatin in the treatment of ovarian carcinoma].
Gan To Kagaku Ryoho. 1982 May;9(5):822-30.